Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myotonic Dystrophy | 3 | 2024 | 187 | 2.380 |
Why?
|
| Ataxin-1 | 6 | 2022 | 171 | 1.830 |
Why?
|
| Alternative Splicing | 3 | 2024 | 610 | 1.610 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2022 | 261 | 1.520 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2024 | 43 | 0.940 |
Why?
|
| Exons | 2 | 2024 | 1388 | 0.880 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 99 | 0.700 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 1016 | 0.560 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 7317 | 0.500 |
Why?
|
| Myotonin-Protein Kinase | 2 | 2024 | 48 | 0.470 |
Why?
|
| RNA Splicing | 2 | 2024 | 362 | 0.400 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2024 | 141 | 0.390 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4105 | 0.380 |
Why?
|
| MicroRNAs | 1 | 2020 | 2882 | 0.280 |
Why?
|
| Interferon Regulatory Factors | 2 | 2017 | 75 | 0.250 |
Why?
|
| Behavior, Animal | 2 | 2021 | 752 | 0.250 |
Why?
|
| Mice | 9 | 2024 | 35421 | 0.240 |
Why?
|
| Protein Stability | 2 | 2021 | 375 | 0.210 |
Why?
|
| Purkinje Cells | 2 | 2022 | 164 | 0.210 |
Why?
|
| Ion Channels | 1 | 2024 | 235 | 0.200 |
Why?
|
| Mortality, Premature | 1 | 2022 | 11 | 0.200 |
Why?
|
| Neural Tube | 1 | 2022 | 51 | 0.200 |
Why?
|
| Neural Crest | 1 | 2022 | 85 | 0.200 |
Why?
|
| Animals | 10 | 2024 | 61357 | 0.190 |
Why?
|
| 14-3-3 Proteins | 1 | 2021 | 141 | 0.180 |
Why?
|
| Alleles | 3 | 2022 | 2598 | 0.170 |
Why?
|
| Skull | 2 | 2022 | 251 | 0.170 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 650 | 0.170 |
Why?
|
| Models, Neurological | 1 | 2021 | 239 | 0.170 |
Why?
|
| Serine | 1 | 2021 | 390 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 7052 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2023 | 2413 | 0.160 |
Why?
|
| Cytoplasm | 1 | 2021 | 702 | 0.160 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 101 | 0.160 |
Why?
|
| Myocardium | 1 | 2024 | 1180 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 1107 | 0.160 |
Why?
|
| Heart | 1 | 2024 | 1173 | 0.150 |
Why?
|
| Cell Line | 3 | 2021 | 5313 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2021 | 4907 | 0.150 |
Why?
|
| Facial Bones | 1 | 2017 | 45 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 120 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 1175 | 0.140 |
Why?
|
| Brain | 2 | 2021 | 4202 | 0.140 |
Why?
|
| Organogenesis | 1 | 2017 | 99 | 0.140 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 132 | 0.140 |
Why?
|
| Tauopathies | 1 | 2016 | 61 | 0.130 |
Why?
|
| Peptides | 1 | 2021 | 1503 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 821 | 0.120 |
Why?
|
| tau Proteins | 1 | 2016 | 215 | 0.120 |
Why?
|
| Lip | 1 | 2014 | 35 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2021 | 5692 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2015 | 376 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 4992 | 0.100 |
Why?
|
| Cysts | 1 | 2014 | 206 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2016 | 889 | 0.100 |
Why?
|
| Cleft Lip | 1 | 2014 | 137 | 0.100 |
Why?
|
| Cleft Palate | 1 | 2014 | 147 | 0.100 |
Why?
|
| Antibodies | 1 | 2015 | 801 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2015 | 491 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 965 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 270713 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2016 | 1716 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 1023 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 1439 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 3435 | 0.070 |
Why?
|
| Mutation | 3 | 2022 | 15917 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 1117 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2022 | 1491 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1458 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 2249 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 489 | 0.050 |
Why?
|
| Risk Factors | 1 | 2020 | 17861 | 0.050 |
Why?
|
| Regulatory Factor X1 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Catenins | 1 | 2022 | 48 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2022 | 145 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 365 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2021 | 231 | 0.040 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 2 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 317 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 631 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2019 | 137 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 3472 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 467 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2019 | 98 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 132 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2017 | 61 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 241 | 0.040 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 27 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Mandible | 1 | 2017 | 189 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 734 | 0.030 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 251 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2015 | 22 | 0.030 |
Why?
|
| Syk Kinase | 1 | 2015 | 65 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 259 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 888 | 0.030 |
Why?
|
| Cell Death | 1 | 2017 | 686 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2015 | 116 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 822 | 0.030 |
Why?
|
| Transcription Factor 3 | 1 | 2014 | 1 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2015 | 233 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 396 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2017 | 7232 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2019 | 5415 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 494 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 4202 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 895 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 3328 | 0.020 |
Why?
|
| Point Mutation | 1 | 2014 | 785 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2015 | 1723 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 14878 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 2040 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 1098 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 4248 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 2356 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 3205 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 5405 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1901 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 6502 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2015 | 2768 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6233 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5145 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 7755 | 0.010 |
Why?
|
| Male | 3 | 2019 | 128479 | 0.010 |
Why?
|
| Female | 3 | 2019 | 148885 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 12042 | 0.010 |
Why?
|